TABLE 1.
Demographic and clinical characteristics of study participants.
| Variable | No antibiotic (n = 15) | Antibiotic (n = 12) | P value |
|---|---|---|---|
| Age (y), mean (SD) | 32.27 (3.8) | 35.25 (4.67) | .07 |
| BMI (kg/m2), mean (SD) | 30.94 (8.1) | 30.48 (7) | .88 |
| Race, no. (%) | 1 | ||
| White | 14 (93.3) | 12 (100) | |
| Asian | 1 (6.7) | 0 (0) | |
| Ethnicity, no. (%) | |||
| Non-Hispanic | 15 (100) | 12 (100) | |
| Duration of infertility (mo), median (IQR) | 24 (18, 48) | 18 (8, 32) | .20 |
| Diagnosis, no. (%) | .35 | ||
| Male factor | 5 (33.3) | 3 (25) | |
| Unexplained | 1 (6.7) | 4 (33.3) | |
| Tubal factor | 2 (13.3) | 1 (8.3) | |
| Endometriosis | 1 (6.7) | 1 (8.3) | |
| Ovulatory dysfunction | 1 (6.7) | 1 (8.3) | |
| PCOS | 4 (26.7) | 0 | |
| DOR | 1 (6.7) | 2 (16.7) | |
| Protocol, no. (%) | .05 | ||
| Long agonist | 9 (60) | 7 (58.3) | |
| Antagonist | 5 (33.3) | 1 (8.3) | |
| Flare | 0 | 4 (33.3) | |
| Luteal E2 flare | 1 (6.7) | 0 | |
| Prior live birth, no. (%) | 1a | ||
| Yes | 3 (20) | 2 (16.7) | |
| No | 12 (80) | 10 (83.3) |
Note: BMI = body mass index; DOR = diminished ovarian reserve; E2 = estradiol; IQR = interquartile range; SD = standard deviation; PCOS polycystic ovary syndrome; SD standard deviation.
a
Fisher’s exact test.